Answers are grounded in this paper and cite their sources.
Background Evaluation of the reproductive efficacy of a modified-live vaccine (MLV) based on porcine reproductive and respiratory syndrome virus-2 (PRRSV-2). Objective The objective of this study was to evaluate the efficacy of a MLV based on porcine PRRSV-2 against a heterologous Korean PRRSV-2 lineage 1 strain challenge in pregnant sows. Animals Twelve pregnant sows from PRRSV-free farms were randomly assigned to three groups (four sows per group). Methods Sows in the vaccinated-challenged group received a 2.0 mL intramuscular dose of PRRSV-2 MLV and were subsequently challenged intranasally with a heterologous PRRSV-2 strain. Results Vaccinated-challenged sows improved reproductive performance, including a higher number of live-born piglets and fewer stillbirths compared with unvaccinated-challenged sows. Viral genomic loads were lower in vaccinated-challenged sows and their offspring as well. Vaccinated-challenged sows also elicited a significantly higher frequency of PRRSV-2 specific interferon- γ secreting cells. Discussion These findings demonstrated that the PRRSV-2 MLV administered to pregnant sows provide protection against heterologous challenge through clinical, virological, and immunological evaluation.
No takes yet. Share an insight, caveat, or question.
Suh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: